Your English writing platform
Discover LudwigSuggestions(3)
Exact(3)
Few adverse events occurred during the index procedure in either treatment group (Table 7).
There were no reports of serious adverse events associated with the TF procedure in either group.
As depicted in Table 3-wrap>, there were no statistically significant differences between patients who had undergone either the transhiatal or the transthoracic procedure in either VAS or standard gamble scores of any health states.
Similar(56)
No mortality was associated with the procedures in either group.
There was no evidence that rabbits that underwent the potentially most painful procedures were more likely to systemic analgesia than rabbits that underwent less potentially painful procedures in either time period.
Begacestat and the GSMs were synthesized according to the procedures reported in either primary publications or patents.
During the study years (1997 2006), there were no endovascular procedures performed in either giant or smaller ICA aneurysms.
No acute cholecystitis or death within 30 days after the procedure was observed in either group.
Both studies have had far-reaching influence in organ transplantation and other procedures in which either bleeding or clotting needs to be strictly controlled.
The concomitant treatments during surgery included 40 mg per day enoxaparin in 10 procedures (23.3%) and tranexamic acid in 11 procedures either in association with FXI (eight procedures, 18.6%) or later (three procedures, 7.0%).
The tables provide a more user-friendly method for calculating the dosimetry for Y-resin microspheres, while at the same including slight modifications to the dosing, in order to improve the safety of this procedure in patients with either a very low (<10 %) or high (>60 %) tumour volume in the liver.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com